Basit öğe kaydını göster

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

dc.contributor.authorYang, Joanna
dc.contributor.authorKaymakoglu, Sabahattin
dc.contributor.authorTamez, Ricardo
dc.contributor.authorTenney, Daniel
dc.contributor.authorBrett-Smith, Helena
dc.contributor.authorShouval, Daniel
dc.contributor.authorLai, Ching-Lung
dc.contributor.authorChang, Ting-Tsung
dc.contributor.authorCheinquer, Hugo
dc.contributor.authorMartin, Paul
dc.contributor.authorCarosi, Glamplero
dc.contributor.authorHan, Steven
dc.date.accessioned2021-03-03T17:50:49Z
dc.date.available2021-03-03T17:50:49Z
dc.date.issued2009
dc.identifier.citationShouval D., Lai C., Chang T., Cheinquer H., Martin P., Carosi G., Han S., Kaymakoglu S., Tamez R., Yang J., et al., "Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy", JOURNAL OF HEPATOLOGY, cilt.50, sa.2, ss.289-295, 2009
dc.identifier.issn0168-8278
dc.identifier.othervv_1032021
dc.identifier.otherav_4bc00f10-267d-4f55-8c8b-f56145759426
dc.identifier.urihttp://hdl.handle.net/20.500.12627/54343
dc.identifier.urihttps://doi.org/10.1016/j.jhep.2008.10.017
dc.description.abstractBackground/Aims: To evaluate the off-treatment durability of response in HBeAg-negative chronic hepatitis B patients who achieved a protocol-defined 'Response' (HBV-DNA < 0.7 MEq/mL and ALT < 1.25 x ULN) with entecavir at 48 weeks and the efficacy of entecavir in patients treated beyond one year.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleRelapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy
dc.typeMakale
dc.relation.journalJOURNAL OF HEPATOLOGY
dc.contributor.departmentThe Hebrew University Of Jerusalem , ,
dc.identifier.volume50
dc.identifier.issue2
dc.identifier.startpage289
dc.identifier.endpage295
dc.contributor.firstauthorID191261


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster